Quote:

---

Maybe patients are skeptical to try an experimental drug?

---

With the safety of ccr5, the news about 98% tumor burden reduction in mice with leronlimab, and the very poor prognosis of TNBC, I think patients will lining up. I assume with the one site opening, they are looking for the patients with ccr5 and getting everything ready for injection. I believe they have to get another pre-treatment before the main chemo begins, taking a little time for results and that.